Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Trials Gone Virtual

As hospitals dealt with spikes in COVID-19 cases and as stay-at-home orders were issued, many researchers working on clinical trials had to pause them, CNBC reports.

But some, it notes, have been able to turn to a virtual clinical trial model in which patients largely participate from home, especially as regulatory rules for virtual trials and reimbursement rules for telemedicine have been eased. Companies like Medable, Science37, and Unlearn.AI provide platforms in this space, it adds. 

A virtual approach may also address issues of travel and time commitments that have plagued traditional clinical trials, according to CNBC, as their setup has limited the ability of working parents and rural residents to participate. However, as virtual trials rely on smartphones and reliable internet access, they may exclude older and lower-income individuals.

Additionally, the approach isn't the right fit for all trials or trial phases, such as phase 1 studies or studies that need, for instance, MRI scans, CNBC says.

Still, CNBC says that a mixture of the approaches might be adopted in the future. "The goal shouldn't be to do everything in the home," Michelle Longmire, the co-founder and CEO of Medable, tells CNBC. "It should be whatever's going to generate the best science and give people the best clinical care.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.